ConductScience.org, home

Gene · 3161

HMMR: hyaluronan mediated motility receptor

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. HMMR: hyaluronan mediated motility receptor. Genes, record 3161. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3161

On this page

Gene

Symbol
HMMR
HGNC
Name
hyaluronan mediated motility receptor
HGNC
NCBI Gene ID
3161
NCBI Gene
HGNC ID
HGNC:5012
HGNC
Ensembl
ENSG00000072571
NCBI Gene
Aliases
CD168, IHABP, RHAMM
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
O75330Hyaluronan mediated motility receptor7240Ensembl, GeneID, HGNC

Source UniProt

Patents47

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4777520 A12026-07-221O75330Espacenet
JP 2026000906 A2026-01-0621O75330Espacenet
EP 4641201 A22025-10-297603O75330Espacenet
EP 4641202 A22025-10-295293O75330Espacenet
JP 2025156269 A2025-10-141O75330Espacenet
JP 2025517969 A2025-06-127603O75330Espacenet
KR 1020250017231 A2025-02-045293O75330Espacenet
EP 4487869 A22025-01-08428O75330Espacenet
JP 2024123008 A2024-09-106514O75330Espacenet
JP 2024509935 A2024-03-0541O75330Espacenet

1 to 10 of 47

See all 47 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,106

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleHMMR papersNewest fiscal year
P30CA008748Cancer Center Support Grant102025
P30CA016672Cancer Center Support Grant82025
P30CA077598Cancer Center Support Grant72025
P20GM103446Delaware INBRE62025
R01DC014461A Hydrogel-Based Cellular Model of the Human Vocal Fold62025
P30CA036727Buffett Cancer Center Support Grant42025
P01CA018029Adult Leukemia Research Center32025
P30CA006973Regional Oncology Research Center32025
P30CA016058Cancer Center Support Grant32025
P30CA076292Moffitt Cancer Center Support Grant32025

1 to 10 of 1,106Source NIH's project files

See all 1,106 nih grants

Papers2,270

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
A human transcriptomic deletion links cortical expansion and cancer.bioRxiv202642779997PubTator, text miningPubMed
RHAMM drives formation of polyploid cancer cells and confers resistance to ER-targeted therapy in breast cancer.Proc Natl Acad Sci U S A202642748147PubTator, text miningPubMed
Hmmr+ Fibroblasts Facilitate Hair Regeneration by Biomechanical Sensing of Extracellular Matrix Viscoelasticity.Research (Wash D C)202642741478PubTator, text miningPubMed
A model of cellular proliferation and mitochondrial biogenesis predicts prognosis and immunotherapy response in lung adenocarcinoma.Transl Cancer Res202642724831PubTator, text miningPubMed
HMMR+ stromal cells drive human uterine development.Cell Discov202642706229PubTator, text miningPubMed
Regulation of TMEM2-mediated hyaluronan degradation by CD44 and LYVE-1.Front Mol Biosci202642656528PubTator, text miningPubMed
Screening of Metabolic Reprogramming-Related Diagnostic Biomarkers and Analysis of Immune Heterogeneity in Atopic Dermatitis Based on Multi-Cohort Validation.Clin Cosmet Investig Dermatol202642605368PubTator, text miningPubMed
MicroRNA Signatures of Fulvestrant-Treated Luminal Breast Cancer Cells: Identification of Therapeutic Targets Regulated by miR-374b-5p.Int J Mol Sci202642589442PubTator, text miningPubMed
An oxidative stress - and immunotherapy-related six-gene signature defines immune subtypes and predicts prognosis and immunotherapy response in hepatocellular carcinoma.Gene202642551718PubTator, text miningPubMed
Identification of telomere-related gene signatures for immune cell infiltration and prognosis in hepatocellular carcinoma.Transl Cancer Res202642445403PubTator, text miningPubMed

1 to 10 of 2,270

See all 2,270 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/3161

GET https://conductscience.org/api/genes/v1/3161/patents?page=2